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postoperative visit (r = 0.25, p = 0.02) but not 








association between MME prescribed and 
fracture characteristics or patient variables.
Conclusion: Postoperative opioid use 









but did not correlate with injury mechanism, 
fracture characteristics, or patient variables. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.063
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Background: The rapidly expanding use 
of antigen targeted therapies, such as anti-
CD19, anti-CD20 and anti-CD22, in B-cell 
malignancies will require the application of 
additional B-cell-associated antigens in the 








surface density changes during normal 
maturation. In contrast to the loss of CD24 
expression in normal follicles, we observed 
that follicle center derived lymphomas retain 
CD24 expression. Our aim was to determine 
the percentage of follicle center lymphomas 
with aberrant CD24 expression.
Methods: We reviewed 334 patients with a 
diagnosis of follicular lymphoma (FL; 228), 
large cell lymphoma of follicular origin 

















tissue diagnosis of FL or diffuse large B-cell 
lymphoma (DLBCL) were excluded leaving 
113 patients with FL, 38 patients with CD10-
positive DLBCL and 12 patients with mixed 
FL/DLBCL. We analyzed the percentage of 
patients with CD24 positive lymphomas in 
each of the three diagnostic categories.
Results: We found that CD24 expression 
was retained in 89% of FLs (101/113), 63% 
(24/38) of DLBCLs and 42% (5/12) of mixed 
FL/DLBCL. Five cases of CD20 negative FL 
were CD24 positive.
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Background: Diffuse large B-cell lymphoma 
(DLBCL) is divided into cell-of-origin (COO) 
groups: germinal center B-cell (GCB), non-
















algorithms, such as the Hans and Choi, were 























Methods: We studied 70 cases of 
DLBCL analyzed with the Lymph2Cx. 
Immunohistochemistry was performed on 
FFPE tissue sections using antibodies for 
CD10, BCL6, MUM1, GCET1 and FOXP1. 
Our aim was to determine the concordance 
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rates between the Lymph2Cx assay and the 
Hans and Choi algorithms were calculated.







































cases (39%) as GCB and 22/36 cases (61%) 











































Choi algorithm and Lymph2Cx assay were 
concordant.
Conclusion: The Lymph2Cx assay is a useful 








and Gold QuantiFERON Tests 
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Background: Nontuberculous mycobacteria 
(NTM) infections are commonly caused 
by Mycobacterium marinum and fortuitum 
with M. marinum more likely to cause skin 
infections. Aquatic environments are a 
potential source of contact with M. marinum 
and fortuitum. Patients with NTM infections 







gold QuantiFERON tests. However, PPD 
cannot differentiate between NTM infection 
and other tuberculous infections caused by 
different mycobacterial strains. We present 
an asymptomatic patient who presented for 
further evaluation of an off-site positive PPD 
and gold QuantiFERON Test. 
Methods: Patient informed consent was 
obtained for this case report.
Results: A 31 year-old, healthy, female 
marine biologist employed in an aquatic 
environment presented to the clinic 
with a positive PPD and a positive gold 
QuantiFERON test. Her job exposes her 
to sea creatures that maybe infected with 
Mycobacterium marinum and fortuitum. She 
denied any history that was suggestive of 
tuberculous infection. A referral was made 
to specialist service for further evaluation 
at which time a repeat gold QuantiFERON 
test was performed and was noted to be 
positive. Following this work up, the patient, 
understanding her likelihood of having 
exposure to M. Marinum and fortuitum, 
preferred to follow a conservative treatment 
approach to monitor for any symptoms of 
active tuberculosis and seek follow up as 
needed. 
Conclusion: Clinicians should not downplay 
the importance of aquatic occupations and 
hobbies in patients who exhibit positive PPD 
and gold QuantiFERON test. Healthcare 
providers should consider NTM infection in 
their differential diagnosis when examining 
patient populations exposed to aquarium 
water, saltwater, and freshwater environments. 
Preventative apparel like waterproof gloves 
can protect the exposed skin from infection. 
Clinicians can prevent NTM infections 
by increasing awareness and promoting 
prevention measures in at-risk populations, 
particularly since infection can be prevented 
with appropriate protective attire. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.074
Chemoembolization of Hepatocellular Carcinoma With Parasitic Blood Supply From the Inferior Phrenic 
Artery
Lei Yu1*, Alex Hodson2*, Timothy Donovan1, Christphor Vargo1
1 University of Nebraska Medical Center, Department of Radiology  
2 University of Nebraska Medical Center, College of Medicine





chemoembolization (TACE) is a commonly 
used embolotherapy for unresectable 
hepatocellular carcinoma (HCC). The 
hepatic artery is usually the vessel of choice, 
however, up to 30% of HCCs can develop 
an extrahepatic collateral (EHC) supply 
and failure to recognize EHC can lead to 
treatment failure. The most common extra 
hepatic artery supplying HCC is the inferior 
phrenic artery (IPA), with right IPA and left 
IPA comprising up to 83% and 12% of all 
collaterals respectively. Certain imaging 
features can help predict the presence of IPA 
collaterals and should be considered at the 
time of treatment.
Methods: We reviewed one recurrent HCC 
after radioembolization and one residual HCC 
after chemoembolization to identify tumor 
characteristics associated with the formation 
of EHC, especially IPA collaterals. Procedural 
considerations during IPA embolization and 
common complications are also reviewed.
Results: Several factors raise the suspicion 
for EHC development, including large 
size, location (segment VII), and prior 
arterial embolization. Avoiding non-target 
embolization is crucial in treatment planning 
as inferior phrenic artery supplies the 
diagram, and rarely, the pericardium and 
bowel. Prophylactic embolization to non-
tumor feeding branches can limit non-target 
embolization.
